BOLTON COMMUNITY PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: Y03079 | BOLTON, BL1 8TT
Showing results 351-400 of 720
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ondansetron hydrochloride | 84 | 4,221 | £1.6K | +73.1% ▲ |
| Hydrocortisone | 84 | 8,043 | £447 | -0.5% vs avg |
| Azelaic acid | 84 | 2,670 | £395 | +251.4% ▲ |
| Typhoid | 84 | 84 | £871 | -6.7% ▼ |
| Clomipramine hydrochloride | 83 | 6,496 | £1.4K | +96.9% ▲ |
| Insulin detemir | 83 | 396 | £3.3K | +6.0% ▲ |
| Dapagliflozin/metformin | 82 | 5,516 | £3.4K | +86.7% ▲ |
| Timolol | 82 | 2,215 | £596 | -7.3% ▼ |
| 82 | 10.0K | £463 | -70.3% ▼ | |
| Hyoscine hydrobromide | 81 | 5,612 | £742 | +137.2% ▲ |
| Sodium feredetate | 81 | 43.9K | £1.3K | +182.8% ▲ |
| Betamethasone esters | 80 | 4,050 | £524 | +32.6% ▲ |
| 80 | 4,240 | £3.1K | +141.9% ▲ | |
| Dulaglutide | 77 | 390 | £7.1K | -32.8% ▼ |
| Pioglitazone hydrochloride | 76 | 2,408 | £188 | -14.1% ▼ |
| 76 | 204 | £1.4K | +112.6% ▲ | |
| Moxonidine | 75 | 3,388 | £522 | +34.7% ▲ |
| Salmeterol | 75 | 88 | £2.7K | +211.8% ▲ |
| Eslicarbazepine acetate | 74 | 2,209 | £3.9K | +231.6% ▲ |
| Rasagiline mesilate | 74 | 1,596 | £1.1K | +99.2% ▲ |
| Methenamine hippurate | 74 | 4,878 | £1.2K | -18.6% ▼ |
| Ipratropium bromide | 73 | 1,609 | £654 | +154.0% ▲ |
| Ketone blood testing reagents | 72 | 780 | £787 | +6.4% ▲ |
| Fesoterodine fumarate | 72 | 2,576 | £531 | +82.5% ▲ |
| Timolol and travoprost | 72 | 288 | £1.2K | +122.8% ▲ |
| Permethrin | 72 | 7,016 | £1.8K | +91.1% ▲ |
| Metoprolol tartrate | 71 | 3,738 | £533 | +40.0% ▲ |
| Pizotifen malate | 71 | 3,272 | £157 | -13.9% ▼ |
| Chlorhexidine gluconate | 71 | 40.3K | £773 | +140.4% ▲ |
| Glucose | 69 | 5,515 | £472 | +32.7% ▲ |
| Sennosides | 68 | 26.7K | £498 | +120.2% ▲ |
| Naftidrofuryl oxalate | 68 | 2,961 | £356 | +108.7% ▲ |
| 68 | 7,627 | £15.2K | +101.4% ▲ | |
| Cinnarizine | 67 | 4,069 | £189 | +43.2% ▲ |
| Powder thickener - starch based (0913161) | 67 | 134.4K | £3.5K | +366.4% ▲ |
| 67 | 700 | £157 | +418.9% ▲ | |
| Zolmitriptan | 66 | 696 | £2.3K | +1.6% vs avg |
| Rifaximin | 66 | 2,156 | £10.0K | +145.8% ▲ |
| Magnesium aspartate | 66 | 2,984 | £2.7K | +335.8% ▲ |
| Dipyridamole | 65 | 4,920 | £1.0K | +153.2% ▲ |
| Desloratadine | 64 | 2,082 | £213 | +121.9% ▲ |
| Lormetazepam | 63 | 1,573 | £479 | +435.0% ▲ |
| Biphasic isophane insulin | 63 | 501 | £2.2K | -43.5% ▼ |
| Metformin hydrochloride/vildagliptin | 62 | 2,172 | £1.2K | +279.4% ▲ |
| Ready to serve 1.5 kcal/ml juice style (0913011) | 62 | 318.8K | £3.2K | +2.0% ▲ |
| 61 | 620 | £1.7K | +27.6% ▲ | |
| 61 | 1,640 | £696 | -21.1% ▼ | |
| Labetalol hydrochloride | 60 | 4,060 | £615 | +164.2% ▲ |
| Dosulepin hydrochloride | 60 | 2,996 | £634 | +6.0% ▲ |
| Atomoxetine hydrochloride | 60 | 2,220 | £3.9K | +77.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.